Immunotherapy and Targeted Therapy in Patients With Advanced Melanoma and the V600 BRAF Mutation: Which One First? D. Moreno-Ramírez, A. Fernández-Orland, L. Ferrándiz

Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management S.J.E. Hwang, R. Anforth, G. Carlos, P. Fernandez-Peñas

RF – Neoadjuvant Therapy in Melanoma A. Arrieta, M. Blanco de Tord, A. Boada